AI주식인사이트AI Stock Insight
B

진바이오텍

086060KOSDAQ산업용 농·축산물 및 동·식물 도매업

55.5 / 100

Reference Date: 2026-04-13

Financial Score28.0 / 40
News Sentiment7.5 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Declined 5.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

JinbioTech operates in two segments: producing functional feed additives and manufacturing animal pharmaceuticals through its subsidiary DaeWon Chemical. The industry faces growing demand for eco-friendly and natural products, requiring technological innovation to overcome challenges like antibiotic resistance. The market benefits from the stable growth of the livestock sector, ensuring consistent demand for its products.

Number of Employees

45people

Average Salary

44.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
11.03Industry Average 16.136.5Point

Lower than industry avg (good)

PBR
0.76Industry Average 0.774.0Point

In line with industry avg

ROE
7.15Industry Average 5.224.0Point

In line with industry avg

Debt Ratio
8.95Industry Average 31.838.0Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲6.9% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼0.4% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 6.1% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 0Negative 1Average Sentiment Score 30

Detailed Momentum

52-week position6.0Point

52w upper range (68%)

Current 4,855Won52-week high 5,55052-week low 3,365
1-month return2.0Point

1m -5.73% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-04-08
  • Neutral주식등의대량보유상황보고서(일반)2026-04-01
  • Neutral사업보고서 (2025.12)2026-03-18
  • Neutral감사보고서제출2026-03-18
  • Neutral주식등의대량보유상황보고서(일반)2026-03-16